Future In Sight

Future In Sight

Download on the App Store

Future In Sight episodes

  • #7 Innovation in the Food and Beverage Industry

    Join Peter and his guest Robert Earl, Vice President of Regulatory Affairs at FARE as they discuss the importance of working with government and regulatory leadership and food industry innovation.

    Hosted by:

    Peter Kolchinsky, Managing Partner RA Capital 

    57 min
  • #6 Future In Sight with Mary Weiser

    Please join us as we welcome Mary Weiser, the new Chair of FARE. In this episode we will discuss with Mary what it means to be chair of FARE & her journey to the chairmanship. We will also discuss Mary's personal experience with food allergies and how has it impacted her life's work and finally Mary's thoughts on the future of FARE.

    Hosted by:

    Peter Kolchinsky, co-founder of RA Capital Management & food allergy dad

    40 min
  • #5 Microbiome

    In this episode, Nurry Hong and podcast host Peter Kolchinsky discuss the the microbiome, its importance, and future developments.

    1 hr 3 min
  • #4 Healthcare: Changing Things for the Better

    Join Peter and his guest, Mariya Filipova, Serial Intrapreneur, as they unpack healthcare needs, services and insurance from the patient perspective and how new technologies, innovation and processes can help transform these industries.

    Hosted by:

    Peter Kulchinsky, biotechnology investor, scientist, & co-founder of RA Capital Management

    58 min
  • #3 Tools for Food Allergy Management

    In this episode, Dr. Kari Nadeau and podcast host Peter Kolchinsky discuss a variety of topics including treatments, therapeutics, diagnostics, prevention, and healthcare. Their conversation will highlight the hope and promise that science has delivered for patients as well as opportunities of whats to come.

    Hosted by:

    Peter Kolchinsky, PhD, Managing Partner, RA Capital

    1 hr 15 min
  • #2 Defeating Food Allergies

    The prevalence of food allergies in the U.S. is greater than it's ever been before, roughly doubling every ten years. Diagnoses of anaphylactic food reactions have risen by 377 percent since 2007, according to recent FARE-commissioned data. To address this concerning trend, Dr. Kari Nadeau, MD, PhD, the director of the Sean N. Parker Center for Allergy Research at Stanford University and FARE's medical advisor for innovation, sat down for an interview with Rob Reid on the "After On" podcast to discuss this public health crisis and the groundbreaking research underway to develop new therapies and diagnostic tools.

    Hosted by:

    Rob Reid, Author and Entrepreneur and Peter Kulchinsky, Biotechnology Investor, Scientist, & Co-Founder of RA Capital Management

    1 hr 50 min
  • #1 Food Allergy Primer

    Join Peter Kolchinsky on his first episode of Future in Sight, a new podcast from FARE. In this episode Peter speaks with Dr. Wayne Shreffler, Director of the Food Allergy Center at Massachusetts General Hospital & Division Chief of Pediatric Allergy and Immunology at MassGeneral Hospital for Children. They will discuss the origins and history of food allergies, how we got to this point in history where 32 million Americans have life-threatening food allergies, and what the future holds for treatments, therapeutics and the next generation.

    Hosted by:

    Peter Kolchinsky, PhD, Managing Partner, RA Capital

     

    1 hr 4 min
  • Future In Sight Trailer

    Peter Kolchinsky can talk at length about the incredible possibilities in immunology - and truly the global health of the species if and when we unlock the keys to understanding and controlling our microbiome. This monthly series will have Peter engaging with equally sharp and unfiltered Geniuses about the potential of solving big picture problems in our lifetimes.

    1 min

About Future In Sight

From the publisher's feed

Peter Kolchinsky can talk at length about the incredible possibilities in immunology - and truly the global health of the species if and when we unlock the keys to understanding and controlling our microbiome.